2020
The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelDrug costsCancer CenterLung cancerEpisode costsMean MedicareYale Cancer CenterClinical trial participationSystemic cancer therapyPart D drug costsCancer therapyLower drug costsCommon cancer typesChi-square testPayment modelsClinical factorsNovel cancer therapiesTrial participationOvarian cancerPatient episodesNovel therapiesCare modelCTR groupPharmaceutical costsAlternative payment modelsThe impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.Peer-Reviewed Original ResearchOncology Care ModelDrug costsMean MedicareYale Cancer CenterMean drug costClinical trial participationSystemic cancer therapyLower drug costsCommon cancer typesChi-square testValue-based payment modelsPayment modelsClinical factorsCancer CenterTrial participationLung cancerEpisode costsCare modelCTR groupAlternative payment modelsCancer typesMean differenceCancer therapyCareEpisodes
2019
Effects of rising drug costs on efforts to control overall cost at a large academic cancer center.
Adelson K, Canavan M, Supalla S, Sedghi T, Chaudhry B, Sinanis N, Gross C. Effects of rising drug costs on efforts to control overall cost at a large academic cancer center. Journal Of Clinical Oncology 2019, 37: 2-2. DOI: 10.1200/jco.2019.37.27_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelLarge academic cancer centerAcute care useAcademic cancer centerPost-acute careMean costCancer CenterCare useDrug costsEmergency department useCost of hospitalizationMean total costValue-based payment programsCost of pharmaceuticalsCancer HospitalCancer careDepartment useTotal episodesInpatient careMedicare claimsCare modelCareEpisodesUtilization categoriesPharmaceutical spendingImpact of an oncology urgent care clinic on emergency department rates.
Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg BE, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.Peer-Reviewed Original ResearchUrgent care clinicED visit ratesSmilow Cancer HospitalVisit ratesProvider visitsED utilizationED visitsCare clinicsUnique patientsEmergency departmentAcute medical attentionUnscheduled emergency departmentRegular clinic visitsCommon cancer typesLower ED utilizationEmergency department ratesFull study sampleTwo-sample t-testClinic visitsSupportive careOncology providersED useSymptom managementCancer HospitalCancer Center
2017
Should Cancer Centers start their own specialty pharmacy? Quality and economic data from the oral chemotherapy program at Smilow Cancer Hospital and Yale New Haven Health System.
Adelson K, Stutsky M, Fradkin M, Harrison M, Abdelghany O, Morrow B, Smith M, Havriliak R, Kregling S, Lyons C, Chiang A, Cohen H. Should Cancer Centers start their own specialty pharmacy? Quality and economic data from the oral chemotherapy program at Smilow Cancer Hospital and Yale New Haven Health System. Journal Of Clinical Oncology 2017, 35: 108-108. DOI: 10.1200/jco.2017.35.8_suppl.108.Peer-Reviewed Original ResearchMedication assistance programsOral chemotherapy programChemotherapy programSpecialty pharmacyYale New Haven Health SystemHealth systemClinical oncology pharmacistSmilow Cancer HospitalPatient assistance programsMultidisciplinary task forceSpecialty pharmacistsCollaborative Improvement ModelHealth-system pharmacyOral chemotherapyCancer HospitalCancer CenterOncologic therapyPrescription errorsOncology pharmacistsTreatment protocolHigh riskPatient callsSpecialty servicesOncologic processesDay 1
2016
Preparing for Value-Based Payment: A Stepwise Approach for Cancer Centers
Adelson KB, Velji S, Patel K, Chaudhry B, Lyons C, Lilenbaum R. Preparing for Value-Based Payment: A Stepwise Approach for Cancer Centers. JCO Oncology Practice 2016, 12: e924-e932. PMID: 27858564, DOI: 10.1200/jop.2016.014605.Peer-Reviewed Original ResearchConceptsSmilow Cancer HospitalEmergency departmentCancer HospitalCancer CenterValue-based paymentMost cancer centersYale-New HavenMedicare Limited Data SetIntensive care unitPatterns of careSite of careUrgent care servicesDay of deathBetter value careStepwise approachED utilizationHospital admissionCare unitUrgent careCare managementCare servicesPatient careHealth system leadershipValue careFutile treatmentUnderstanding total cost of cancer care to determine strategic interventions to improve value.
Adelson K, Velji S, Patel K, Chaudhry B, Grizzle S, Lyons C, Lilenbaum R. Understanding total cost of cancer care to determine strategic interventions to improve value. Journal Of Clinical Oncology 2016, 34: 4-4. DOI: 10.1200/jco.2016.34.7_suppl.4.Peer-Reviewed Original ResearchSmilow Cancer HospitalAcademic cancer centerCost of careED visitsED utilizationHospital admissionCancer CenterHospital admissions/readmissionsLarge academic cancer centerAdmissions/readmissionsMedicare Limited DatasetAcademic medical centerElements of careSite of serviceValue-based payment modelsEarly referralAggressive treatmentICU useCancer HospitalPalliative careCancer careUrgent careFirst episodeMedicare patientsMedical Center
2013
Development of a new oncology quality metric: The rate of evidence-based adherence.
Adelson K, Holcombe R. Development of a new oncology quality metric: The rate of evidence-based adherence. Journal Of Clinical Oncology 2013, 31: 84-84. DOI: 10.1200/jco.2013.31.31_suppl.84.Peer-Reviewed Original ResearchEvidence-based adherenceClinical evidenceEvidence-based practiceEvidence-based clinical pathwayElectronic health recordsNCCN guidelinesBreast groupDose modificationCancer CenterDisease groupClinical trialsClinical pathwayPatient careProportion of protocolsHealth recordsProvider ratesAdherenceGroup rateElectronic protocolFirst cycleGroupWide variationChemotherapyNumber of timesIndividual protocols